CLC Producing Winterized Cannabis Oil in Commercial Quantities, Characterized by a Unique Terpene Profile with Potential Medicinal Applications
Ryan Allway
January 5th, 2021
News, Top News
VANCOUVER, British Columbia, Jan. 05, 2021 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that it has commenced commercial production of winterized cannabis oil as well as full-spectrum winterized cannabis oil, using crude oil extracted in-house from biomass grown by the Company during its inaugural grow season in 2020 in which 32,500 kg / 71,650 lb of cannabis was cultivated outdoors. The Company’s winterized cannabis oils contain a unique terpene profile which has potential applications in medicinal products. CLC currently continues its dealings with potential purchasers of its initial supply of cannabis oils as announced in its press release dated December 23, 2020. Samples of the Company’s cannabis oils are to be shared with potential purchasers in the coming weeks.
Terpenes play a significant role in the marketability of cannabis goods, largely due to their role in a product’s aromatics as well as their ability to enhance the effects of cannabidiol (“CBD”) and/or tetrahydrocannabinol (“THC”) creating what is referred to as the “Entourage Effect”. Commonly, terpenes are also used as a diluent to reduce the viscosity of certain cannabis oils (as shown in the second image below). The terpene profiles that are unique to CLC’s proprietary strains of cannabis are considered to be desirable in the medicinal cannabis market.
The non-invasive nature of cannabis extraction done using CO2 power also tends to allow for greater terpene yields. Based on an initial batch of oils extracted using the Company’s CO2-powered Vitalis R-200-H-GMP-SS, the Company has observed an impressive concentration of terpenes. In a report by Deloitte1, the Canadian market for products made with cannabis extracts was estimated to be worth approximately CAD $1.6 billion, or nearly 60% of the CAD $2.7 billion market size of “Cannabis 2.0”.
In addition to winterized and full-spectrum winterized cannabis oil, the Company is also producing a supply of cannabis oil with an extra-high THC concentration, which is known as “distillate”.
Bhavana Rao, Director of Extraction and Product Development for the Company commented, “Our portfolio of proprietary cannabis strains is engineered to flourish when grown under natural sunlight. In terms of biomass quantity, this has been evidenced by our inaugural harvest yielding more than double the initially forecasted amount. We are thrilled to be extracting oils and terpenes from strains grown outdoors in the famous Kootenay region. Consumers’ tastes become more sophisticated as the cannabis market matures, with many cannabis users’ preferences now being based on terpenes or terpene profiles. Large-scale CO2 extraction allows us to meet the growing demand for full-spectrum products in the industry. With CO2 extraction techniques, we have the ability to pre-extract and re-introduce terpenes that are strain specific. With growing demand for cannabis extracts in the global cannabis marketplace, we take great pride in our proprietary methodologies for developing and growing proprietary strains as well as for the extraction of oils for emerging applications in areas such as medical cannabis.”
Milan Stefancik, Director of Sales for the Company commented, “There is significant demand for cannabis extracts in Canada, which can primarily be attributed to their versatility in products under ‘Cannabis 2.0’. Another attractive element of extracts is their long shelf life, which allows for a very lean supply chain from the extractor to the end consumer. We have been in discussions with potential purchasers of our initial batch of winterized and full-spectrum winterized cannabis oil for a couple of weeks now, and we look forward to bringing our cannabis oil products one step closer to the retail and medicinal markets.”
Sources
1 – Deloitte: Nurturing new growth – Canada gets ready for Cannabis 2.0
About Christina Lake Cannabis Corp.
Christina Lake Cannabis Corp. is a licensed producer of cannabis under the Cannabis Act. It has secured a standard cultivation licence and corresponding processing/sales amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development licence (early 2020). CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. CLC also owns a 99-acre plot of land adjoining its principal 32-acre site, which enables the Company to grow at a much larger scale. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and in its inaugural harvest year produced 32,500 kg (71,650 lb) on its existing facility before developing an adjacent 99-acre expansion property. Such an expansion will ultimately bring CLC’s annual cultivation footprint to over 4.35 million square feet, which could enable at least 150,000 kg (330,693 lb) of low-cost, high-quality, sun-grown cannabis to be produced annually by the Company.
On behalf of Christina Lake Cannabis Corp.:
“Joel Dumaresq”
Joel Dumaresq, CEO and Director
For more information about CLC, please visit: www.christinalakecannabis.com
Jamie Frawley
Investor Relations
jamie@clcannabis.com
416-268-9432
Jordan Owens
Media Inquiries
jordan.owens@hkstrategies.ca
236-818-5969
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.
Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements.” The use of any of the words “anticipate,” “continue,” “estimate,” “expect,” “may,” “will,” “would,” “project,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on http://www.sedar.com.
Statement Regarding Third-Party Investor Relations Firms
Disclosures relating to investor relations firms retained by Christina Lake Cannabis Corp. can be found under the Company’s profile on http://sedar.com.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/f6683228-e1b9-4512-8945-25579c025c1f
https://www.globenewswire.com/NewsRoom/AttachmentNg/857d6e3a-6a6e-41e1-9d1c-2f68c831c5c6
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Amercanex was founded with the sole-purpose to ensure a completely transparent, neutral, and non-manipulated marketplace for cannabis industry participants.
Harborside Inc. (CSE: HBOR) is one of the oldest, largest and most respected cannabis retailers in the world with award-winning flower, concentrates, edibles and other cannabis products from California’s most respected growers and manufacturers.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
